Affordable Access

deepdyve-link
Publisher Website

Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial.

Authors
  • Subramanian, M L
  • Abedi, G
  • Ness, S
  • Ahmed, E
  • Fenberg, M
  • Daly, M K
  • Houranieh, A
  • Feinberg, E B
Type
Published Article
Journal
Eye (London, England)
Publication Date
Nov 01, 2010
Volume
24
Issue
11
Pages
1708–1715
Identifiers
DOI: 10.1038/eye.2010.147
PMID: 20885427
Source
Medline
License
Unknown

Abstract

The 1-year outcomes of a prospective, double-masked, randomised clinical trial comparing bevacizumab with ranibizumab failed to show a difference in visual and anatomic outcomes between the two treatments for choroidal neovascularisation in AMD. Total injections given over the treatment period were significantly different between the two groups. Further studies with larger sample sizes are warranted.

Report this publication

Statistics

Seen <100 times